Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Medical Device Manufacturing in Nantong

An employee of a medical company is presenting a sample of a pan-vascular medium implant catheter in Nantong City, Jiangsu Province, China on July 24, 2025.

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (R) tests a new generation of OCT equipment at a laboratory of a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascu

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui attends a video conference on his way to a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012,

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (R) talks with his colleague at a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 19, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012, he gave u

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (R) learns about the use of OCT equipment at Beijing Anzhen Hospital in Beijing, capital of China, Feb. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012, he gave up his do

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui adjusts equipment at a laboratory of Institute of Physics of the Chinese Academy of Sciences in Beijing, capital of China, Jan. 12, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (L) talks with a researcher at a laboratory of Institute of Physics of the Chinese Academy of Sciences in Beijing, capital of China, Jan. 12, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular s

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (L) talks with a doctor about the use of OCT equipment at Beijing Anzhen Hospital in Beijing, capital of China, Feb. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012, he g

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (back) observes doctors using OCT equipment at Beijing Anzhen Hospital in Beijing, capital of China, Feb. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012, he gave up his

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui and his colleagues discuss the research progress of OCT technology at a laboratory of a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT te

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui adjusts OCT equipment at a laboratory of a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 18, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012,

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui (R) talks with his partner Dr. Mi Lei in Xi'an, northwest China's Shaanxi Province, Jan. 19, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012, he gave up his doctoral studies

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- Zhu Rui attends a video conference with experts at a branch office of Vivolight in Xi'an, northwest China's Shaanxi Province, Jan. 19, 2024. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012

E

CHINA-BEIJING-OCT TECHNOLOGY-ENTREPRENEURSHIP (CN)

(240220) -- BEIJING, Feb. 20, 2024 (Xinhua) -- This photo taken on Jan. 12, 2024 shows a portrait of Zhu Rui. On Feb. 18, the first working day after China's Spring Festival holiday, Zhu Rui, founder of medical device company Vivolight, came to the catheter operating room of Beijing Anzhen Hospital to learn about the use of OCT equipment produced by his company. OCT, or optical coherence tomography technology, allows doctors to examine patients and display real-time three-dimensional images where the catheter passes, providing guide for surgery. Since graduating from Tsinghua University in 2006, Zhu has been engaged in OCT related research and product development. His role has changed from a student, a researcher to an entrepreneur. While studying in Beijing, Zhu built an OCT system for ophthalmology. While studying for his PhD in Hong Kong, he realized the potential value of OCT technology in cardiovascular surgery. In 2012, he gave up his doctoral studies and tried to transform the achievements in h

E

(CIIE) CHINA-SHANGHAI-CIIE-EXHIBITION (CN)

(221105) -- SHANGHAI, Nov. 5, 2022 (Xinhua) -- An ablation catheter used for heart ultrasonic testing is displayed at the medical equipment and health care products exhibition area of the fifth China International Import Expo (CIIE) at the National Exhibition and Convention Center (Shanghai) in east China's Shanghai, Nov. 5, 2022. Many first-time exhibits are showcased during the expo, which kicked off in Shanghai on Saturday. (Xinhua/Jin Liwang)

E

(CIIE) CHINA-SHANGHAI-CIIE-EXHIBITION (CN)

(221105) -- SHANGHAI, Nov. 5, 2022 (Xinhua) -- An ablation catheter is displayed at the medical equipment and health care products exhibition area of the fifth China International Import Expo (CIIE) at the National Exhibition and Convention Center (Shanghai) in east China's Shanghai, Nov. 5, 2022. Many first-time exhibits are showcased during the expo, which kicked off in Shanghai on Saturday. (Xinhua/Ding Ting)

E

Catella's catheter "Rikishi" (right). Drilled hole in guiding catheter.

Catella (Taito-ku, Tokyo) has developed and launched a new catheter called "Rikishi" for the treatment of completely occluded lesions in the shallow femoral artery. The catheter has a hole in the side of the guiding catheter so that guidewires and devices used for treatment can be inserted through the hole while the catheter is inserted into the deep femoral artery. This makes it easier to approach the shallow femoral artery. The price is 24,000 yen. The company aims to sell 1,000 units per year. The guiding catheter is inserted into the deep femoral artery until the hole on the side is at the position of the shallow femoral artery. The guidewire can be inserted into the catheter and then released through the hole on the side. However, the guidewire operation is difficult and time-consuming. The company hopes to contribute to the diversification of treatment methods by spreading the use of Lixi. Photo taken on June 18, 2019, credit: Nikkan Kogyo Shimbun / Kyodo News Images

E

Drug-coated balloon catheter that Maeda Corporation aims to sell in 2010

Maeda Kosen has invested about 2.2 billion yen in MedAlliance, a Swiss medical device venture, and signed an agreement to exclusively market a new drug-coated balloon for the treatment of peripheral artery disease in Japan. The company believes that the new drug will be highly effective in catheterizing blood vessels for lower limb artery disease from the waist down, and aims to start clinical trials in Japan in 2020 and sales in 2010. MedAlliance, established in 2008, has the technology to apply sirolimus, an immunosuppressant agent, to the film material of the balloon. The technology applies sirolimus when the balloon is expanded in the blood vessel to prevent the onset of re-narrowing after the procedure. The balloon will be named "Celluon" and is planned to be sold worldwide around 2010. Maeda Kosen will be responsible for introducing it in Japan. Photo taken on June 28, 2019, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images

E

What Doesn'T Kill You (2008)

Amanda Peet & Mark Ruffalo Characters: Stacy Reilly, Brian Reilly Film: What Doesn'T Kill You (USA 2008) Director: Brian Goodman 10 September 2008 Date: 10 September 2008

E

Catch-22 (1970)

Bandaged Man In Hospital Film: Catch-22 (1970) Director: Mike Nichols 24 June 1970 Date: 24 June 1970

E

Teleflex medical devices producer production plant, central venous catheter, CVC

Teleflex medical devices producer organized an open house in Hradec Kralove, Czech Republic, on November 10, 2018. On the photo is seen a central venous catheter (CVC). (CTK Photo/David Tanecek)

E